Comparing high and low dose iron for people on peritoneal dialysis
Treatments studied
Part of Blood & lymphatic, Hormones & metabolism clinical trials.
This trial tests whether a higher or lower dose of iron works better for people on peritoneal dialysis who have low iron levels. It aims to find the best way to treat iron deficiency in this group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been on peritoneal dialysis for at least 4 weeks and are expected to stay on it.
- Your iron levels (ferritin and transferrin saturation) are below certain limits.
- You have not had intravenous iron in the last 4 weeks.
- You are not pregnant and use effective birth control if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an intravenous (IV) iron treatment called iron isomaltoside for people on peritoneal dialysis who have anemia (low red blood cells). It aims to improve your hemoglobin and iron levels, which may help you feel more energetic and reduce fatigue.
This trial tests whether a new blood test (reticulocyte hemoglobin) is better than the usual iron test (transferrin saturation) for guiding when to give iron to people on dialysis. If you have anemia (low red blood cells) from kidney disease, this study may help doctors find the best way to treat your iron levels.
This study compares two different doses of IV iron (low vs high) to see which works better for people with heart failure and low iron levels. It may help you feel less tired and breathe easier.
This study compares two intravenous iron treatments to see if one works as well as the other in people with iron deficiency anemia. It may help improve your iron levels and reduce anemia symptoms.
This trial tests whether giving iron through an IV can help older adults with heart failure who also have low iron levels. It aims to see if this treatment improves symptoms and quality of life.
This study tests whether giving intravenous iron improves symptoms, quality of life, and exercise ability in people with heart failure and low iron levels. Participants will receive iron infusions and be monitored over time to see if their condition improves.
Hear when a new Peritoneal Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.